Altea Therapeutics Announces Senior R&D Management Appointments to Align Product Development with Needs of Commercialization Partners

Published: May 05, 2009

ATLANTA--(BUSINESS WIRE)--Altea Therapeutics, a leader in advanced transdermal drug delivery systems, announced today senior R&D appointments to strengthen its product development and commercialization capabilities and to align technical operations with the needs of its alliance partners, including Amylin Pharmaceuticals Inc., Eli Lilly and Company, and Hospira, Inc.

Back to news